Category: News

RAMP Enables Automated Contextual Videos With Launch of MetaQ

One of the main things content providers can do to create rich user experiences is present contextualized content that relates to the underlying article or

Vabiotech Licenses Cell-Based Japanese Encephalitis Technology from Inviragen

Hanoi, Vietnam & Fort Collins, CO – January 3, 2013 – The Company for Vaccine and Biological Production No.1 (VABIOTECH) and Inviragen, Inc. today announced

goBalto Raises $12 Million in Series B Financing from EDBI and Qualcomm Ventures

SAN FRANCISCO, Dec. 27, 2012 /PRNewswire/ — goBalto, Inc. (www.gobalto.com) announced today that it closed a $12 million round of venture financing, led by EDBI,

Ezion Pursues Growth Strategy to Accelerate Its International Expansion Plans

Singapore, 18 December 2012 – Ezion Holdings Limited (“Ezion” and together with its subsidiaries the “Group”), a leading Singapore headquartered, offshore logistics support service provider,

OptiMedica Receives FDA Market Clearance of the Catalys Precision Laser System

SANTA CLARA, Calif. — December 22, 2011— Global ophthalmic company OptiMedica Corp.

Sotera Wireless Completes $12.2M Series D Financing, Signs Agreement With Cerner

SAN DIEGO – December 7, 2011 – Sotera Wireless, Inc. today announced the completion of a $12.2 million Series D financing led by Singapore-based global

Mobile Rich Media Pioneer Crisp Media Announces Acquisition of Smart Device Media Creating Integrate

Smart Device Media Co-Founder and Former Ziff Davis CEO, Jason Young to lead the Combined Company

Inviragen Presents Safety and Immune Response Data from a P1 Study of its Two-Dose Dengue Vaccine

Fort Collins, CO – December 7, 2011 – Inviragen, Inc. presented results of the Phase 1 clinical trial of DENVax conducted in Colombia at the

Crisp Media Partners with Domob to Deliver Rich Media Mobile Ads in China

Campaign for Singapore Tourism Board: China’s First Rich Media Campaign to Follow International MRAID Standards

Forest Laboratories and Adamas Pharmaceuticals Enter into Licensing Agreement for the Development

NEW YORK & EMERYVILLE, CA ‐‐ Forest Laboratories, Inc. (NYSE: FRX), an international pharmaceutical company, and Adamas Pharmaceuticals, Inc. announced today that they have